Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 923093 STAMFORD, CT
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,458,785
+$376,654 QoQ
Shares Held
131,914
+24.3% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#91
of 271 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. ARQT ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in ARQT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,458,785 131,914
2025-12-31 $3,082,131 106,134
2025-09-30 $1,319,123 69,980
2025-03-31 $1,616,753 103,373
2024-12-31 $896,172 64,334
2024-09-30 $194,965 20,964
2024-03-31 $2,029,359 204,779
2023-09-30 $241,397 45,461
2023-03-31 $333,366 30,306
2022-09-30 $350,649 18,349